Also on Trial Friend:ALK-Positive Lung Cancer pageCompare treatmentsMatch Me
All 23 ALK-Positive Lung Cancer trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCMost sites in Florida, New York and CaliforniaRecruitingPhase 3Ages 18+Nuvalent22US sites
14 states - A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCMost sites in Massachusetts, Ohio and CaliforniaRecruitingPhase 1/2Ages 18+TRIANA Biomedicines14US sites
12 states - A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Most sites in California, Colorado and GeorgiaRecruitingPhase 1Ages 18+Astellas Pharma Global Development9US sites
8 states - Gilteritinib for the Treatment of ALK NSCLCMost sites in California, District of Columbia and MichiganRecruitingPhase 1Ages 18+University of Michigan Rogel Cancer Center3US sites
3 states - AQUA07 in Patients With ALK-Positive Non-Small Cell Lung CancerOnly in TexasRecruitingPhase 1Ages 18+Chugai Pharmaceutical1US site
- Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung CancerOnly in TexasRecruitingPhase 2Ages 18+M.D. Anderson Cancer Center1US site
- Patient-centered, Optimal Integration of Survivorship and Palliative CareOnly in MassachusettsRecruitingAges 18+Massachusetts General Hospital1US site
- Study of NXP900 With Lorlatinib in ALK+ Lung CancerOnly in VirginiaRecruitingPhase 1Nuvectis Pharma1US site
- A Real World Study of Ensartinib in Advanced ALK-positive NSCLCRecruitingAges 18+Peking Union Medical College HospitalNo US site yet
- A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on LorlatinibRecruitingPhase 2Ages 18+Centro di Riferimento Oncologico - AvianoNo US site yet
- Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung CancerRecruitingPhase 2Ages 18-75Hebei Medical University Fourth HospitalNo US site yet
- Alectinib Pharmacokinetic in Patients With NSCLCRecruitingPhase 1/2Ages 18+Instituto Nacional de Cancerologia de MexicoNo US site yet
- Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLCRecruitingAges 18+Groupe Francais De Pneumo-CancerologieNo US site yet
- Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World ContextRecruitingAges 18+PfizerNo US site yet
- Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort StudyRecruitingAges 18+Guangdong Association of Clinical TrialsNo US site yet
- Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After LorlatinibRecruitingAges 18+Peking University Shenzhen HospitalNo US site yet
- Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLCRecruitingPhase 2Ages 18+Guangdong Association of Clinical TrialsNo US site yet
- Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)RecruitingPhase 1/2Ages 18-75Tang-Du HospitalNo US site yet
- Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung CancerRecruitingPhase 2Ages 18+Pingping SongNo US site yet
- Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCTRecruitingPhase 3Ages 18-99Tata Memorial HospitalNo US site yet
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the ALK-Positive Lung Cancer trials in the US, and what stage they are in
Of the 9 ALK-Positive Lung Cancer trials with a US site, 1 is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 7 of them. The last one has no drug phase, such as a study that follows people over time or tests a device or a way of giving care. Companies run 5 of them, and universities, hospitals, foundations and government groups run 4. The most recently listed one first appeared on ClinicalTrials.gov on November 16, 2026.
ALK-Positive Lung Cancer trials in the US, state by state
Of the 9 ALK-Positive Lung Cancer trials with a US site, 1 accepts children under 18. Its open sites are in Virginia. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 9 states
US hospitals running the most ALK-Positive Lung Cancer trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know ALK-Positive Lung Cancer.
- Massachusetts General HospitalBoston, Massachusetts2 trials
- NEXT VirginiaFairfax, Virginia2 trials
- SCRI Oncology PartnersNashville, Tennessee2 trials
- University of Cincinnati Cancer CenterCincinnati, Ohio2 trials
- AdventHealth Cancer InstituteOrlando, Florida1 trial
- Alliance Cancer SpecialistsSellersville, Pennsylvania1 trial
- Brigham and Women's HospitalBoston, Massachusetts1 trial
- Carolinas Medical CenterCharlotte, North Carolina1 trial
- Cedars-Sinai Medical CenterLos Angeles, California1 trial
- Compass OncologyVancouver, Washington1 trial
Help getting to an ALK-Positive Lung Cancer trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Corporate Angel Network
- Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
- American Cancer Society Hope Lodge
- Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding an ALK-Positive Lung Cancer trial near you
Are there ALK-Positive Lung Cancer clinical trials near me?
As of November 20, 2026, 23 ALK-Positive Lung Cancer clinical trials are recruiting now and 21 are not yet recruiting. In the US, 9 of them have at least 1 open site, across 18 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have ALK-Positive Lung Cancer clinical trial sites?
Recruiting ALK-Positive Lung Cancer trials list open sites in 18 states and Washington, DC. California, Massachusetts and Texas have the most, and the table on this page lists every state.
Are there ALK-Positive Lung Cancer trials for children near me?
Of the 9 ALK-Positive Lung Cancer trials with a US site, 1 accepts children under 18. Its open sites are in Virginia. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to an ALK-Positive Lung Cancer clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.
What if there is no ALK-Positive Lung Cancer trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when an ALK-Positive Lung Cancer trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for ALK-Positive Lung Cancer: Nelkarmi (neladalkib), Lorbrena (lorlatinib), Alecensa (alectinib), Alunbrig (brigatinib), Ensacove (ensartinib), Xalkori (crizotinib), Zykadia (ceritinib).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 20, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.
